tetrahydrogestrinone
Sign in to saveAlso known as 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE
Tetrahydrogestrinone (THG), known by the nickname The Clear, is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use. It was developed by Patrick Arnold and was used by a number of high-profile athletes such as Barry Bonds and Dwain Chambers.
Research
50 papers- Tetrahydrogestrinone analysis and designer steroids revisited.Bioanalysis · 2009
- Tetrahydrogestrinone: discovery, synthesis, and detection in urine.Rapid communications in mass spectrometry : RCM · 2004
- Tetrahydrogestrinone: the discovery of a designer steroid.Current sports medicine reports · 2005
- Tetrahydrogestrinone is a potent androgen and progestin.The Journal of clinical endocrinology and metabolism · 2004
- Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.Toxicology letters · 2006
via PubMed
~6 min read
Encyclopedic overview
8 sectionsContents
- Non-medical uses
- Side effects
- Pharmacology
- Pharmacodynamics
- Chemistry
- History
- References
- External links
Tetrahydrogestrinone (THG), known by the nickname The Clear, is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use. It was developed by Patrick Arnold and was used by a number of high-profile athletes such as Barry Bonds and Dwain Chambers.
==Non-medical uses== THG was developed completely in secret by Patrick Arnold as a designer drug, on the basis that doping testers would be unlikely to detect a totally new compound. Arnold developed a chemical similar to two obscure steroids marketed by BALCO, norbolethone and desoxymethyltestosterone, which had been reported in scientific literature but never entered mass production, and the banned anabolic steroids trenbolone and gestrinone, the latter of which was used to synthesize it.
Excerpted from Wikipedia’s “tetrahydrogestrinone” article, available under the CC BY-SA 4.0 licence.